We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tim-3 Proteins Shut Down Immune Attack

By Biotechdaily staff writers
Posted on 18 Nov 2003
Researchers have found that the Tim-3 surface protein found on TH1-type helper T cells plays a key role in regulating immune response through modulation of helper cell activity in order to prevent tissue inflammation and development of autoimmune diseases.

Investigators at Harvard Medical School (Boston, MA, USA) used a line of mice with autoimmune diabetes, a condition known to be caused by a TH1 response against insulin-producing cells, to show that the Tim-3 pathway blockade accelerated diabetes in nonobese diabetic mice and prevented acquisition of transplantation tolerance induced by co-stimulation blockade. More...
These findings were published in two papers in the November 2003 issue of Nature Immunology.

"Activated TH1-type helper T cells both participate in and help orchestrate the attack on cells bearing proteins, thereby guarding against infection,” explained senior author Terry Strom, M.D., professor of medicine at Harvard Medical School. "The particular pattern of Tim-3 expression that was found in these two studies suggests that it plays a key role in squelching activation of TH1 T-cells. Nature must have wanted us to have such a mechanism so that once you have created immunity, you have a timely means of ‘turning off' the immune attack.”




Related Links:
Harvard Medical School

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.